Noah Berkowitz
CIK 1369900 · Chief Medical Officer · last filed 2026-05-13
Noah Berkowitz is a Chief Medical Officer who has filed 20 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $110.4K of ARVN on May 13, 2026. Across all open-market trades the lifetime net is −$323.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.76M
3
20
-$323.8K
Holdings By Company
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-13 | ARVN | Sell (S) | −11,108 | -$110.4K | EDGAR |
| 2026-03-19 | ARVN | Sell (S) | −6,435 | -$71.4K | EDGAR |
| 2026-03-02 | ARVN | Grant (A) | +45,000 | $0 | EDGAR |
| 2026-02-18 | ARVN | Sell (S) | −5,685 | -$67.6K | EDGAR |
| 2025-05-13 | ARVN | Grant (A) | +59,600 | $0 | EDGAR |
| 2025-03-19 | ARVN | Sell (S) | −8,658 | -$74.4K | EDGAR |
| 2025-02-18 | ARVN | Grant (A) | +55,229 | $0 | EDGAR |
| 2024-03-21 | ARVN | Grant (A) | +63,452 | $0 | EDGAR |
| 2008-12-03 | Synvista Therapeutics, Inc. (SYI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-24 | Synvista Therapeutics, Inc. (SYI) Delisted | Grant (A) | — | $0 | EDGAR |